Cargando…
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes
BACKGROUND: The prevalence of non-alcoholic fatty liver disease (NAFLD) has been increasing rapidly. It is nowadays recognized as the most frequent liver disease, affecting a quarter of global population and regularly coexisting with metabolic disorders such as type 2 diabetes, hypertension, obesity...
Autores principales: | Godoy-Matos, Amélio F., Silva Júnior, Wellington S., Valerio, Cynthia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359287/ https://www.ncbi.nlm.nih.gov/pubmed/32684985 http://dx.doi.org/10.1186/s13098-020-00570-y |
Ejemplares similares
-
Dipeptidyl Peptidase 4: A New Link between Diabetes Mellitus and Atherosclerosis?
por: da Silva Júnior, Wellington Santana, et al.
Publicado: (2015) -
The role of glucagon on type 2 diabetes at a glance
por: Godoy-Matos, Amélio F
Publicado: (2014) -
Is Metabolic Syndrome Useful for Identifying Youths with Obesity at Risk for NAFLD?
por: Di Bonito, Procolo, et al.
Publicado: (2023) -
Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
por: Kim, Hyunmi, et al.
Publicado: (2021) -
The Link between NAFLD and Metabolic Syndrome
por: Radu, Fabiana, et al.
Publicado: (2023)